FRN 111627/Canadian Institutes of Health Research/Canada[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2014	1
2015	2
2016	1
2025	0

Page 1

siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer.

Yamamoto Y, Lin PJ, Beraldi E, Zhang F, Kawai Y, Leong J, Katsumi H, Fazli L, Fraser R, Cullis PR, Gleave M. Yamamoto Y, et al. Clin Cancer Res. 2015 Nov 1;21(21):4845-55. doi: 10.1158/1078-0432.CCR-15-0866. Epub 2015 Jun 23. Clin Cancer Res. 2015. PMID: 26106075

Production of limit size nanoliposomal systems with potential utility as ultra-small drug delivery agents.

Zhigaltsev IV, Tam YK, Leung AK, Cullis PR. Zhigaltsev IV, et al. J Liposome Res. 2016;26(2):96-102. doi: 10.3109/08982104.2015.1025411. Epub 2015 Apr 9. J Liposome Res. 2016. PMID: 25856305

Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.

Chen S, Tam YY, Lin PJ, Leung AK, Tam YK, Cullis PR. Chen S, et al. J Control Release. 2014 Dec 28;196:106-12. doi: 10.1016/j.jconrel.2014.09.025. Epub 2014 Oct 5. J Control Release. 2014. PMID: 25285610

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year